|
WO2021074530A1
|
|
System for improved interaction in a virtual world
|
|
WO2021001348A1
|
|
Method for preparing biological material for microscopy analysis
|
|
WO2020212597A1
|
|
p16INK4a INHIBITOR FOR PREVENTING OR TREATING HUNTINGTON'S DISEASE
|
|
WO2020193782A1
|
|
Implantable ultrasound generating device for implantation within a vertebral column
|
|
WO2020188100A2
|
|
Roscovitine analogues and use thereof for treating rare biliary diseases
|
|
WO2020099224A1
|
|
Haptic interface
|
|
EP3811937A1
|
|
Compounds for use in the prevention and/or treatment of non-alcoholic fatty liver disease
|
|
FR3102357A1
|
|
ANALOGUES OF N-ACYL-HOMOSERINE LACTONS AND PHARMACEUTICAL COMPOSITION INCLUDING THEM
|
|
WO2020065203A1
|
|
Ocular observation method and device, and biometric application
|
|
WO2020020906A2
|
|
Methods for diagnosing a cerebral amyloid angiopathy by amyloid beta autoantibodies
|
|
WO2020016517A1
|
|
Ocular observation device
|
|
FR3098432A1
|
|
ROBOTIC TRACTION MODULE
|
|
FR3097862A1
|
|
NEW METALLIC OR HETEROMETALLIC COMPLEXES WITH ANTI-CANCER PROPERTIES
|
|
EP3794128A1
|
|
Molecular tools and methods for transgene integration and their transposition dependent expression
|
|
FR3094204A1
|
|
Device for controlling a robotic system for assisting the mobility of a user
|
|
WO2020183215A1
|
|
Separator, process for manufacturing said separator and sodium ion batterie comprising said separator
|
|
WO2019170766A1
|
|
Compositions and methods for efficent amplification of retinal progenitors cells
|
|
US2020368373A1
|
|
Optical imaging agents targeting inflammation
|
|
WO2019145483A1
|
|
Molecular signature and use thereof for the identification of indolent prostate cancer
|
|
EP3650036A1
|
|
Synthetic peptides inducing immunogenic cell death
|
